Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29687996 | 1.00 | CYP3A4 (0.48) | CYP3A4CASP3SENP8SENP7SENP6 | |
| Methane SCHEMBL27501832 | 0.98 | CYP3A4 (0.47) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL112824 | 0.86 | CYP3A4 (0.56) | CYP3A4ALDH1A1HSD17B10HPGDMAPK1 | |
| SCHEMBL29770893 | 0.86 | CYP3A4 (0.44) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL692232 | 0.86 | CYP3A4 (0.44) | CYP3A4CASP3SENP8SENP7SENP6 | |
| Methane SCHEMBL29088144 | 0.84 | CYP3A4 (0.42) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL113386 | 0.84 | CYP3A4 (0.47) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL7585382 | 0.84 | CYP3A4 (0.52) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL11613354 | 0.84 | PTGS2 (0.43) | CYP3A4CASP3SENP8SENP7SENP6 | |
| SCHEMBL29099802 | 0.84 | CYP3A4 (0.54) | CYP3A4ALDH1A1HSD17B10HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3581600-B1 | RESIN LENS AND PREPARATION METHOD THEREFOR | EFIRM NEW MAT CO LTD (CN) | 2025-01-08 | — | — | EP | claimed |
| US-20240327352-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE | MSN LABORATORIES PRIVATE LTD, R&D CENTER (IN) | 2024-10-03 | — | — | US | claimed |
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | ENEVATE CORP (US) | 2024-10-03 | — | — | US | claimed |
| CN-118599216-A | Antiallergic composite material and preparation method thereof | 天茂石化江苏有限公司 | 2024-09-06 | — | — | CN | claimed |
| CN-115787192-B | Preparation method of regenerated cowhide fiber synthetic leather | 峰安皮业股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-116769094-A | Binuclear vanadium catalyst containing binghAC ligand, and preparation method and application thereof | 合肥工业大学 | 2023-09-19 | — | — | CN | claimed |
| CN-116589407-A | Synthesis method of 6-aryl phenanthridine compound | 湖南科技学院 | 2023-08-15 | — | — | CN | claimed |
| CN-115093365-B | Synthesis method of raffinacine | 沈阳药科大学 | 2023-07-25 | — | — | CN | claimed |
| WO-2023002502-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE | MSN LABORATORIES PRIVATE LTD, R&D CENTER (IN) | 2023-01-26 | — | — | WO | claimed |
| CN-115093365-A | Synthesis method of lefenacin | 沈阳药科大学 | 2022-09-23 | — | — | CN | claimed |
| CN-101056701-A | Low-viscosity microcapsule dispersions | BASF AG (DE) | 2007-10-17 | — | — | CN | claimed |
| CN-100335029-C | Aerosol device containing a condensation polymer comprising at least polyurethane and/or polyurea unit | LAYA CO LTD (FR) | 2007-09-05 | — | — | CN | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| CN-1292675-A | Aerosol device containing a condensation polymer comprising at least polyurethane and/or polyurea unit | OREAL (FR) | 2001-04-25 | — | — | CN | claimed |
| CN-1275066-A | Hair composition comprising a polycondensate comprising at least one polyurethane and/or polyurea unit and a polyol | OREAL (FR) | 2000-11-29 | — | — | CN | claimed |
| CN-1275067-A | Aerosol device containing a polycondensate comprising at least one polyurethane and/or polyurea unit | OREAL (FR) | 2000-11-29 | — | — | CN | claimed |
| US-4607439-A | AIR PERMEABLE MULTILAYER SHEET OF WATER AND OIL REPELLENT FABRIC AND RUBBER LAYER | ACHILLES CORPORATION (JP) | 1986-08-26 | — | — | US | claimed |
| EP-0019349-B1 | STABILIZING COMPOSITION FOR POLYARYLENE ESTERS, STABILIZED POLYARYLENE ESTER, MOULDED ARTICLE PRODUCED THEREFROM AND PROCESS FOR STABILIZING A POLYARYLENE ESTER | MONSANTO COMPANY (US) | 1983-08-03 | — | — | EP | claimed |
| EP-0019349-A1 | Stabilizing composition for polyarylene esters, stabilized polyarylene ester, moulded article produced therefrom and process for stabilizing a polyarylene ester | MONSANTO COMPANY (US) | 1980-11-26 | — | — | EP | claimed |
| US-4222932-A | MOLDING MATERIALS STABILIZED BY ADDING AN AROMATIC ISOCYANATE AND AN ALIPHATIC PHOSPHITE | MONSANTO COMPANY (US) | 1980-09-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240332628-A1 | Silicon-Based Energy Storage Devices With Electrolyte Containing Cyanate Based Compounds | SIRT3, SLC6A12, HCN2 | CYP3A4 4039/4885CASP3 1745/4885SENP8 2896/4885 |
| US-20240327352-A1 | NOVEL PROCESS FOR THE PREPARATION OF 1-(2-{4-[(4-CARBAMOYLPIPERIDIN-1-YL)METHYL]- N-METHYLBENZAMIDO}ETHYL)PIPERIDIN-4-YL N-({1,1'-BIPHENYL}-2-YL)CARBAMATE | CYP4B1, CYP1B1, KDM4B | CYP3A4 12/4885CASP3 704/4885SENP8 2026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.